Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Filters applied: . Clear all
Page 1
A placebo-controlled, double-blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis.
König P, Poehler J, Barbero GJ. König P, et al. Among authors: barbero gj. Pediatr Pulmonol. 1998 Jan;25(1):32-6. doi: 10.1002/(sici)1099-0496(199801)25:1<32::aid-ppul3>3.0.co;2-q. Pediatr Pulmonol. 1998. PMID: 9475328 Clinical Trial.
Home measurements of PEFR showed a significant improvement of 4.7% on albuterol and a non-significant change of 2.0% on placebo from the first to the last week of treatment. None of the long-term improvements (spirometry or home PEFR) correlated with mean daily bronchodila …
Home measurements of PEFR showed a significant improvement of 4.7% on albuterol and a non-significant change of 2.0% on placebo from the fir …
Short-term and long-term effects of albuterol aerosol therapy in cystic fibrosis: a preliminary report.
König P, Gayer D, Barbero GJ, Shaffer J. König P, et al. Among authors: barbero gj. Pediatr Pulmonol. 1995 Oct;20(4):205-14. doi: 10.1002/ppul.1950200402. Pediatr Pulmonol. 1995. PMID: 8606849 Clinical Trial.
Frequent bronchodilator responders were accurately predicted by their baseline bronchodilator responsiveness, but not by age or personal or family history of asthma or atopy. No difference in long-term pulmonary function improvements were noted between frequent and infrequ …
Frequent bronchodilator responders were accurately predicted by their baseline bronchodilator responsiveness, but not by age or personal or …
A longitudinal study of bronchodilator responsiveness in cystic fibrosis.
Hordvik NL, König P, Morris D, Kreutz C, Barbero GJ. Hordvik NL, et al. Among authors: barbero gj. Am Rev Respir Dis. 1985 Jun;131(6):889-93. doi: 10.1164/arrd.1985.131.6.889. Am Rev Respir Dis. 1985. PMID: 4003942
All but 1 subject (95%) showed a significant bronchodilator response at least once on an outpatient basis; nonhospitalized subjects were responsive 49% of the time. Bronchodilator responsiveness was unrelated to long-term pulmonary severity or indexes of atopy but it was s …
All but 1 subject (95%) showed a significant bronchodilator response at least once on an outpatient basis; nonhospitalized subjects were res …